Journal
LIFE SCIENCES
Volume 253, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.lfs.2020.117572
Keywords
PPAR gamma, hepatic stellate cell; microRNA-942; Liver fibrosis
Funding
- National Natural Science Foundation of China [81803898, 81673788, 81873136, 81803232]
- Peak Discipline of Colleges and Universities in Shanghai [A-U151902]
- Putuo Hospital Fund [2016204B, 2017207A]
- Xinglin Scholar of Shanghai University of Traditional Chinese Medicine
- Health System Independent Innovation Science Foundation of Shanghai Putuo District [ptkwws201817, ptkwws201904]
Ask authors/readers for more resources
Aims: Liver fibrosis is a chronic liver disease characterized by hepatic stellate cell (HSC) activation. Peroxisome proliferator-activated receptor gamma (PPAR gamma) play an important role in HSC activation. This study aimed to investigate the role of PPAR gamma in the progression of human hepatic fibrosis and the mechanism by which microRNA-942 regulates HSC activation. Methods: 70 chronic hepatitis B (CHB) patients liver tissues were used to assess PPAR gamma, alpha-SMA and miR-942 levels by immunoblot and real-time PCR. Human primary HSCs or LX2 cells were used to perform multiple molecular experiments based on the transfection of small interfering RNA (siRNA) or co-transfection of microRNA inhibitor. Site-directed mutagenesis and luciferase reporter assays were used to identify miR-942 targets. miR-942 expression and localization in hepatic fibrosis and co-localization between alpha-SMA were determined by fluorescence in situ hybridization (FISH). Key findings: The mRNA expression of PPAR gamma was decreased in activated HSCs and CHB patients with liver fibrosis, which was negatively correlated with F stage and alpha-SMA. miR-942 negatively regulates PPAR gamma expression via targeting the PPAR gamma 3'UTR Inhibiting PPAR gamma promoted TGF beta 1 induced HSC activation, and this effect was blocked after inhibiting the miR-942. Moreover, miR-942 was mainly expressed in fibrous septa and negatively correlated with PPAR gamma in liver fibrosis. Significance: PPAR gamma targeting by miR-942 and decreasing HSC activation in human hepatic fibrosis. Hence, regulating PPAR gamma may be a promising therapeutic strategy for hepatic fibrosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available